Clinical Trial Update: Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders

View source ↗

Summary

This clinical trial update reports a real-world assessment of brexpiprazole (Rexulti) for schizophrenia and depressive disorders, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• REXULTI (brexpiprazole)

Snippet

Sponsor: Dr. Albert Kar-Kin Chung | Conditions: Psychosis, Depression | Status: RECRUITING